The optimal use of contrast agents at high field MRI

Bilateral ce-MR angiography of the hands at 3.0 T and 1.5 T: intraindividual comparison of quantitative and qualitative image parameters in healthy volunteers

The purpose of this study was to determine the benefit of bilateral contrast-enhanced MR angiography (ce-MRA) of the hands at 3.0 Tesla (T) compared with an established 1.5-T technique in healthy volunteers. Intraindividual bilateral ce-MRA of the hands was performed at 1.5 T and 3.0 T in 14 healthy volunteers using a timed ultra-fast GRE sequence featuring parallel acquisition. The evaluation comprised measurement of the vessel signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR), rating of the image quality and the assessment of artefacts and venous contamination. At 3.0 T, SNR improved up to 95% and CNR up to 129%. The image quality of the larger inflow arteries, the palm arches and common digital arteries was good or sufficient at either magnetic field strengths. However, 3.0-T MRA was clearly superior in the depiction of the digital arteries. Ce-MRA of the hand clearly profits from the use of 3.0 T. Compared with 1.5 T, a substantial increase of CNR is found resulting in a significantly better delineation of the small digital arteries. Saturation affects more the SNR of the perivascular tissue than the contrast-enhanced blood, and thus leads to a marked increase of CNR at 3.0.

Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies

RATIONALE AND OBJECTIVES

To determine the sensitivity of susceptibility-weighted imaging (SWI) for depicting hemorrhagic hypointense foci of the brain in comparison with gradient-recalled echo (GRE)- and GRE-type single-shot echo-planar imaging (GREI, GRE-EPI), and to assess the basic characteristics of the susceptibility effect by using a phantom.

MATERIALS AND METHODS

We prospectively examined 16 patients (9 males, 7 females, aged 10-74 years, mean 43 years) with hypointense foci using SWI, GREI, and GRE-EPI at a 1.5-T magnetic resonance (MR) unit. The contrast-to-noise ratio (CNR), sensitivity to small hypointese foci, and artifacts were evaluated. To assess the basic characteristics of SWI, we performed a phantom study using different concentrations of superparamagnetic iron oxide (SPIO).

RESULTS

The CNR of lesions was significantly greater for SWI than the other images (P < .0001). SWI detected the greatest number of small hypointense foci, even in the near-skull-base and infratentorial regions. Quantitative and qualitative analyses in our clinical and phantom studies demonstrated that the degree of artifacts was similar with SWI and GREI.

CONCLUSION

SWI was best for detecting small hemorrhagic hypointense foci. Artifacts of SWI were similar to GREI.

Body and Cardiovascular MR Imaging at 3.0 T

Potential advantages of magnetic resonance (MR) imaging at 3 T include higher signal-to-noise ratios, better image contrast, particularly in gadolinium-enhanced applications, and better spectral separation for spectroscopic applications. In terms of clinical imaging, these advantages can mean higher-spatial-resolution images, faster imaging, and improved MR spectroscopy. However, achieving superior imaging and spectroscopic quality at 3 T can be challenging. This review discusses many of the problems encountered in body and cardiovascular MR imaging at 3 T, such as increased susceptibility, B1 field inhomogeneity, and increased specific absorption rate. The article also considers solutions that are being pursued, such as parallel imaging, variable-rate selective excitation, and variable flip angle sequences. A review of the most commonly used pulse sequences provides practical tips on how these can be optimized for 3-T imaging. In the coming few years, substantial improvements in 3-T technology for clinical imaging and spectroscopy will undoubtedly be seen. An understanding of the basic principles on which these developments are based will help radiologists translate the advances into better imaging studies and, ultimately, better patient care.

Kidneys and MR Urography

Clinically useful images of the kidneys, ureters, and bladder can be generated routinely on a 3T MR scanner. Although little has been published directly comparing 3.0-T MR imaging of the urinary tract with 1.5T imaging, the same benefits and limitations that apply to other areas of the body apply to urinary tract imaging at 3T. The potential benefits of improved signal-to-noise ratio and conspicuity of gadolinium enhancement and the potential for functional MR imaging of the kidneys at 3T are compelling, but need to be investigated further.

High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings

BACKGROUND AND PURPOSE

The purpose of this work was to demonstrate susceptibility effects (SusE) in various types of brain tumors with 3T high-resolution (HR)-contrast-enhanced (CE)-susceptibility-weighted (SW)-MR imaging and to correlate SusE with positron-emission tomography (PET) and histopathology.

MATERIALS AND METHODS

Eighteen patients with brain tumors, scheduled for biopsy or tumor extirpation, underwent high-field (3T) MR imaging. In all of the patients, an axial T1-spin-echo (SE) sequence and an HR-SW imaging sequence before and after IV application of a standard dose of contrast agent (MultiHance) was obtained. Seven patients preoperatively underwent PET. The frequency and formation of intralesional SusE in all of the images were evaluated and correlated with tumor grade as determined by PET and histopathology. Direct correlation of SusE and histopathologic specimens was performed in 6 patients. Contrast enhancement of the lesions was assessed in both sequences.

RESULTS

High-grade lesions demonstrated either high or medium frequency of SusE in 90% of the patients. Low-grade lesions demonstrated low frequency of SusE or no SusE. Correlation between intralesional frequency of SusE and histopathologic, as well as PET, tumor grading was statistically significant. Contrast enhancement was equally visible in both SW and SE sequences. Side-to-side comparison of tumor areas with high frequency of SusE and histopathology revealed that intralesional SusE reflected conglomerates of increased tumor microvascularity.

CONCLUSIONS

3T HR-CE-SW-MR imaging shows both intratumoral SusE not visible with standard MR imaging and contrast enhancement visible with standard MR imaging. Because frequency of intratumoral SusE correlates with tumor grade as determined by PET and histopathology, this novel technique is a promising tool for noninvasive differentiation of low-grade from high-grade brain tumors and for determination of an optimal area of biopsy for accurate tumor grading.

Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model

RATIONALE AND OBJECTIVES

To estimate the gain in signal-to-noise ratio (SNR) in first-pass contrast-enhanced (CE) abdominal magnetic resonance angiography (MRA) at 3.0 T compared with 1.5 T.

MATERIALS AND METHODS

Three protocols were simulated using six contrast agents: gadopentetate dimeglumine (Magnevist, Berlex, Wayne, NJ), gadoteridol (Prohance, Bracco, Princeton, NJ), gadobenate dimeglumine (Multihance, Bracco, Princeton, NJ), gadodiamide (Omniscan, Amersham Health, Princeton, NJ), gadoversetamide (Optimark, Mallinckrodt, St. Louis, MO), and gadofosveset trisodium (MS-325, EPIX Medical, Cambridge, MA). Contrast concentrations were calculated for five abdominal vessels. Based on these data, the gain in SNR during CE abdominal MRA at 3.0 T over 1.5 T was estimated.

RESULTS

In these simulations, peak concentrations in all five target vessels were about 5 mM, 10 mM, and 0.7 mM for protocol 1, protocol 2, and protocol 3, respectively. A gain in SNR at 3 T over 1.5 T during CE abdominal MRA of at least 94% in all five target vessels could be achieved by applying protocol 1 or protocol 2, whereas protocol 3 provided a gain in SNR of 70%.

CONCLUSIONS

Although five of the contrast agents studied fulfill the expectation of providing approximately twice the SNR at 3.0 T versus 1.5 T during CE abdominal MRA, MS-325 offers a gain in SNR of 70% only.

High-field-strength magnetic resonance: potential and limits

OBJECTIVE

To expatiate on the possible advantages and disadvantages of high magnetic field strengths for magnetic resonance imaging and, in particular, for magnetic resonance angiography.

METHODS AND RESULTS

A review of the available literature is given, presenting many of the advantages and disadvantages of imaging at higher field strengths. Focus is put on imaging at 3 to 7 T. Early results at 7 T are presented; these results indicate that several of the angiographic techniques commonly used at lower field strengths show promise for improvement by taking advantage of the higher signal and susceptibility sensitivity at 7 T.

CONCLUSIONS

The drive toward higher field strengths, both for the purpose of fundamental research and for clinical diagnostic imaging, is likely to continue. New applications using the unique properties of high field strength will almost certainly emerge as researchers gain more experience. The ultimate limiting factor is likely to be the physiological effects at high field strengths. However, this limit seems to lie at field strengths higher than 7 T because early experience shows good tolerance of 7 T examinations.

Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications

Brain tumors are one of the most common neoplasms in young adults and are associated with a high mortality and disability rate. Magnetic resonance imaging (MRI) is widely accepted to be the most sensitive imaging modality in the assessment of cerebral neoplasms. Because the detection, characterization, and exact delineation of brain tumors require a high lesion contrast that depends on the signal of the lesion in relation to the surrounding tissue, contrast media is given routinely. Anatomical and functional, contrast agent-based MRI techniques allow for a better differential diagnosis, grading, and especially therapy decision, planing, and follow-up. In this article, the basics of contrast enhancement of brain tumors will be reviewed. The underlying pathology of a disrupted blood-brain barrier and drug influences will be discussed. An overview of the currently available contrast media and the influences of dosage, field strength, and application on the tumor tissue contrast will be given. Challenging, contrast-enhanced, functional imaging techniques, such as perfusion MRI and dynamic contrast-enhanced MRI, are presented both from the technical side and the clinical experience in the assessment of brain tumors. The advantages over conventional, anatomical MRI techniques will be discussed as well as possible pitfalls and drawbacks.

Detection of brain metastasis at 3T: comparison among SE, IR-FSE and 3D-GRE sequences

The objective of this study is to compare the detectability of brain metastases at 3T among three contrast-enhanced sequences, spin-echo (SE) sequence, inversion recovery fast SE (IR-FSE) sequence (both with section thickness of 6 mm), and three-dimensional fast spoiled gradient-echo (3D fast SPGR) sequence with 1.4 mm isotropic voxel. First, phantom studies were performed to quantify the contrast-enhancement ratio (CER) with three sequences. In 21 consecutive patients with brain metastases, axial images of three sequences at 3T were obtained after administration of gadoteridol. Two neuroradiologists assessed the detectability of brain metastases for the three sequences. In the phantom study, no evident difference in the CER was demonstrated among three sequences. Significantly more brain metastases were detected with 3D fast SPGR than with SE and IR-FSE (a total of 97 lesions with 3D fast SPGR vs. 64 with SE and 63 with IR-FSE). In particular, 3D fast SPGR was superior to the other two sequences in detection of the small lesions (<3 mm). At 3T, the contrast-enhanced 3D fast SPGR with 1.4 mm isotropic voxel is clinically more valuable for detecting small brain metastases than the SE and IR-FSE with section thickness of 6 mm.

Proton MR spectroscopy of the brain at 3 T: an update

Proton magnetic resonance spectroscopy ((1)H-MRS) provides specific metabolic information not otherwise observable by any other imaging method. (1)H-MRS of the brain at 3 T is a new tool in the modern neuroradiological armamentarium whose main advantages, with respect to the well-established and technologically advanced 1.5-T (1)H-MRS, include a higher signal-to-noise ratio, with a consequent increase in spatial and temporal resolutions, and better spectral resolution. These advantages allow the acquisition of higher quality and more easily quantifiable spectra in smaller voxels and/or in shorter times, and increase the sensitivity in metabolite detection. However, these advantages may be hampered by intrinsic field-dependent technical issues, such as decreased T(2) signal, chemical shift dispersion errors, J-modulation anomalies, increased magnetic susceptibility, eddy current artifacts, challenges in designing and obtaining appropriate radiofrequency coils, magnetic field instability and safety hazards. All these limitations have been tackled by manufacturers and researchers and have received one or more solutions. Furthermore, advanced (1)H-MRS techniques, such as specific spectral editing, fast (1)H-MRS imaging and diffusion tensor (1)H-MRS imaging, have been successfully implemented at 3 T. However, easier and more robust implementations of these techniques are still needed before they can become more widely used and undertake most of the clinical and research (1)H-MRS applications.

Imaging the female pelvis at 3.0 T

Three-Tesla whole body imaging is rapidly becoming part of routine clinical practice. Although it is generally thought that pelvic imaging at 3.0 T will be beneficial because of increased signal to noise and greater spectral separation, adjustments in protocol and sequence parameters are necessary to optimize image quality. The question remains as to whether 3.0-T imaging will offer further benefits beyond 1.5 T in terms of lesion characterization and functional imaging. This article aims to address safety concerns and to illustrate the potential benefits and technical challenges of imaging the female pelvis at 3.0 T. Imaging protocols and sequence parameters for routine gynecologic indications are suggested, and potential clinical applications at 3.0 T are discussed such as magnetic resonance spectroscopy, perfusion, diffusion weighted imaging, and the use of alternate contrast agents.

3D MRI in multiple sclerosis: a study of three sequences at 3 T

The objective of this study was to assess the feasibility of using 3D acquisition at 3 T for imaging patients with multiple sclerosis (MS). Feasibility was assessed by three criteria based on acquisition time, specific absorption rate (SAR) and image quality. 47 patients with clinically definite MS underwent imaging in a Siemens 3T Trio MR scanner. Patient safety data were obtained following the scan sessions. The study had local ethics approval. The following three-dimensional (3D) sequences, all acquired coronally, were used: T2 fluid attenuated inversion recovery (FLAIR) (repetition time (TR) 6000 ms, echo time (TE) 353 ms, inversion time (TI) 2200 ms), 0.5x0.5x1 mm voxels, acquisition time 10 min 38 s; T2 turbo spin echo (TSE) (TR 3000 ms, TE 354 ms), 1x1x1 mm voxels, acquisition time 8 min 29 s; T1 inversion recovery (IR) (TR 2040 ms, TE 5.56 ms, TI 1100 ms), matrix 512x448 (0.5x0.5 mm pixels), 0.5x0.5x1 mm voxels, acquisition time 7 min 38 s. Total acquisition time was 26 min 45 s. Example images are presented. 3D scanning at 3 T provides highly detailed, high quality images with acquisition times tolerated by MS patients, even by those with severe disability. The volumetric data are suitable for a wide variety of post-processing techniques; the authors suggest that 3D studies at 3 T should be considered as the possible brain imaging protocol for either cross-sectional or longitudinal studies in MS and that the 3D T2 FLAIR sequence should be considered for the purposes of radiological diagnosis.